Definium Therapeutics
A Senior Director, Pricing & Contracting at Definium Therapeutics develops and executes pricing and contracting strategy, government price reporting, and contract operations for their product. The role ensures pricing decisions reflect market dynamics and payer expectations while working cross-functionally with senior leadership and other teams.
Headquarters
New York, New York, United States
Company Size
1-10 employees
Founded
2019
Definium Therapeutics (formerly MindMed) is a clinical-stage biopharmaceutical company harnessing the therapeutic potential of psychedelic medicine to develop treatments for psychiatric conditions including generalized anxiety disorder, major depressive disorder, and autism spectrum disorder. Its lead programs include DT120 ODT, a proprietary formulation of lysergide (LSD) D-tartrate, and DT402, the R-enantiomer of MDMA targeting core symptoms of autism spectrum disorder. The company is guided by precision science and evidence-based development to redefine mental healthcare.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Definium Therapeutics.
132% above the average for this role
Director, Government Pricing & Contract Operations
Dyne Therapeutics
Senior Director, Pricing and Contracting
Mineralys Therapeutics
Director, Market Access
Milestone Pharmaceuticals
Manager, Payer Contracting
OpenLoop Health
Value & Access Contracting Partner
UCB
Executive Director, U.S. Pricing & Contracting
Servier